General Information of the Protein
Protein ID
PT01128
Protein Name
Tyrosine-protein kinase receptor UFO
Secondarily
Protein Name
AXL oncogene
Gene Name
AXL
Secondarily
Gene Name
UFO
Sequence
MAWRCPRMGRVPLAWCLALCGWACMAPRGTQAEESPFVGNPGNITGARGLTGTLRCQLQVQGEPPEVHWLRDGQILELADSTQTQVPLGEDEQDDWIVVSQLRITSLQLSDTGQYQCLVFLGHQTFVSQPGYVGLEGLPYFLEEPEDRTVAANTPFNLSCQAQGPPEPVDLLWLQDAVPLATAPGHGPQRSLHVPGLNKTSSFSCEAHNAKGVTTSRTATITVLPQQPRNLHLVSRQPTELEVAWTPGLSGIYPLTHCTLQAVLSDDGMGIQAGEPDPPEEPLTSQASVPPHQLRLGSLHPHTPYHIRVACTSSQGPSSWTHWLPVETPEGVPLGPPENISATRNGSQAFVHWQEPRAPLQGTLLGYRLAYQGQDTPEVLMDIGLRQEVTLELQGDGSVSNLTVCVAAYTAAGDGPWSLPVPLEAWRPGQAQPVHQLVKEPSTPAFSWPWWYVLLGAVVAAACVLILALFLVHRRKKETRYGEVFEPTVERGELVVRYRVRKSYSRRTTEATLNSLGISEELKEKLRDVMVDRHKVALGKTLGEGEFGAVMEGQLNQDDSILKVAVKTMKIAICTRSELEDFLSEAVCMKEFDHPNVMRLIGVCFQGSERESFPAPVVILPFMKHGDLHSFLLYSRLGDQPVYLPTQMLVKFMADIASGMEYLSTKRFIHRDLAARNCMLNENMSVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPADCLDGLYALMSRCWELNPQDRPSFTELREDLENTLKALPPAQEPDEILYVNMDEGGGYPEPPGAAGGADPPTQPDPKDSCSCLTAAEVHPAGRYVLCPSTTPSPAQPADRGSPAAPGQEDGA
    Show/Hide
Organism
Homo sapiens, Human
Protein Classification
Enzyme
>
Kinase
>
Protein Kinase
>
TK protein kinase group
>
Tyrosine protein kinase Axl family
Function
Receptor tyrosine kinase that transduces signals from the extracellular matrix into the cytoplasm by binding growth factor GAS6 and which is thus regulating many physiological processes including cell survival, cell proliferation, migration and differentiation. Ligand binding at the cell surface induces dimerization and autophosphorylation of AXL. Following activation by ligand, AXL binds and induces tyrosine phosphorylation of PI3-kinase subunits PIK3R1, PIK3R2 and PIK3R3; but also GRB2, PLCG1, LCK and PTPN11. Other downstream substrate candidates for AXL are CBL, NCK2, SOCS1 and TNS2. Recruitment of GRB2 and phosphatidylinositol 3 kinase regulatory subunits by AXL leads to the downstream activation of the AKT kinase. GAS6/AXL signaling plays a role in various processes such as endothelial cell survival during acidification by preventing apoptosis, optimal cytokine signaling during human natural killer cell development, hepatic regeneration, gonadotropin-releasing hormone neuron survival and migration, platelet activation, or regulation of thrombotic responses. Also plays an important role in inhibition of Toll-like receptors (TLRs)-mediated innate immune response.
    Show/Hide
Uniprot ID
Primary ID:
P30530

Secondarily ID:
Q8N5L2
Q9UD27
    Show/Hide
Ensembl ID
ENSG00000167601
HGNC ID
HGNC:905
Subcellular Location
Cell membrane
Map of Molecular Bioactivity Related to the Protein
Map of Molecular Bioactivity Related to the Protein

Protein
Cell Line
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Protein
Cell Line ID: CL000077 , Ba/F3
Compound ID Compound Name Compound Formula
CP0317631
N-[2,5-difluoro-4-[2-[[4-(4-methylpiperazin-1-yl)piperidine-1-carbonyl]amino]pyridin-4-yl]oxyphenyl]-3-(4-fluorophenyl)-2,4-dioxo-1-propan-2-ylpyrimidine-5-carboxamide
   Show/Hide
C36H39F3N8O5
 1
1
IC50 = 1.9 nM
   TI
   LI
   LO
   TS
CP0563520
1-cyclopentyl-N-[3-fluoro-4-[2-[[2-(1-methylpiperidin-4-yl)acetyl]amino]pyridin-4-yl]oxyphenyl]-3-(4-fluorophenyl)-2,4-dioxopyrimidine-5-carboxamide
   Show/Hide
C35H36F2N6O5
 1
1
IC50 = 2.8 nM
   TI
   LI
   LO
   TS
CP0564219
3-(4-fluorophenyl)-N-[4-[2-[[2-(1-methylpiperidin-4-yl)acetyl]amino]pyridin-4-yl]oxyphenyl]-2,4-dioxo-1-propan-2-ylpyrimidine-5-carboxamide
   Show/Hide
C33H35FN6O5
 1
1
IC50 = 5.9 nM
   TI
   LI
   LO
   TS
CP0553501
1-cyclopentyl-3-(4-fluorophenyl)-N-[4-[6-[[4-(4-methylpiperazin-1-yl)piperidine-1-carbonyl]amino]pyrimidin-4-yl]oxyphenyl]-2,4-dioxopyrimidine-5-carboxamide
   Show/Hide
C37H42FN9O5
 1
1
IC50 = 6.3 nM
   TI
   LI
   LO
   TS
CP0557698
N-[2-fluoro-4-[2-[[2-(1-methylpiperidin-4-yl)acetyl]amino]pyridin-4-yl]oxyphenyl]-3-(4-fluorophenyl)-2,4-dioxo-1-propan-2-ylpyrimidine-5-carboxamide
   Show/Hide
C33H34F2N6O5
 1
1
IC50 = 7.6 nM
   TI
   LI
   LO
   TS
CP0557697
N-[4-[6-(cyclopropanecarbonylamino)pyrimidin-4-yl]oxyphenyl]-3-(4-fluorophenyl)-2,4-dioxo-1-propan-2-ylpyrimidine-5-carboxamide
   Show/Hide
C28H25FN6O5
 1
1
IC50 = 9 nM
   TI
   LI
   LO
   TS
CP0543363
N-[4-[6-(azetidine-1-carbonylamino)pyrimidin-4-yl]oxyphenyl]-3-(4-fluorophenyl)-2,4-dioxo-1-propan-2-ylpyrimidine-5-carboxamide
   Show/Hide
C28H26FN7O5
 1
1
IC50 = 11 nM
   TI
   LI
   LO
   TS
CP0553500
3-(4-fluorophenyl)-N-[4-[6-[[4-(4-methylpiperazin-1-yl)piperidine-1-carbonyl]amino]pyrimidin-4-yl]oxyphenyl]-2,4-dioxo-1-propan-2-ylpyrimidine-5-carboxamide
   Show/Hide
C35H40FN9O5
 1
1
IC50 = 15 nM
   TI
   LI
   LO
   TS
CP0554517
3-(4-fluorophenyl)-2,4-dioxo-1-propan-2-yl-N-[4-[6-(pyrrolidine-1-carbonylamino)pyrimidin-4-yl]oxyphenyl]pyrimidine-5-carboxamide
   Show/Hide
C29H28FN7O5
 1
1
IC50 = 15 nM
   TI
   LI
   LO
   TS
CP0553502
N-[2,5-difluoro-4-[2-[[4-(4-methylpiperazin-1-yl)piperidine-1-carbonyl]amino]pyridin-4-yl]oxyphenyl]-2,5-dioxo-1-phenyl-7,8-dihydro-6H-quinoline-3-carboxamide
   Show/Hide
C38H39F2N7O5
 1
1
IC50 = 16 nM
   TI
   LI
   LO
   TS
CP0563667
3-(4-fluorophenyl)-N-[4-[6-[(3-hydroxyazetidine-1-carbonyl)amino]pyrimidin-4-yl]oxyphenyl]-2,4-dioxo-1-propan-2-ylpyrimidine-5-carboxamide
   Show/Hide
C28H26FN7O6
 1
1
IC50 = 20 nM
   TI
   LI
   LO
   TS
CP0554516
1-cyclopropyl-N-[3-fluoro-4-[2-[[2-(1-methylpiperidin-4-yl)acetyl]amino]pyridin-4-yl]oxyphenyl]-3-(4-fluorophenyl)-2,4-dioxopyrimidine-5-carboxamide
   Show/Hide
C33H32F2N6O5
 1
1
IC50 = 23 nM
   TI
   LI
   LO
   TS
CP0317628
3-(4-fluorophenyl)-N-[4-[6-[[3-(methylamino)azetidine-1-carbonyl]amino]pyrimidin-4-yl]oxyphenyl]-2,4-dioxo-1-propan-2-ylpyrimidine-5-carboxamide
   Show/Hide
C29H29FN8O5
 1
1
IC50 = 40 nM
   TI
   LI
   LO
   TS
CP0317629
3-(4-fluorophenyl)-2,4-dioxo-1-propan-2-yl-N-[4-[6-[(3-pyrrolidin-1-ylazetidine-1-carbonyl)amino]pyrimidin-4-yl]oxyphenyl]pyrimidine-5-carboxamide
   Show/Hide
C32H33FN8O5
 1
1
IC50 = 49 nM
   TI
   LI
   LO
   TS
CP0566934
1-cyclopropyl-3-(4-fluorophenyl)-N-[4-[6-[[4-(4-methylpiperazin-1-yl)piperidine-1-carbonyl]amino]pyrimidin-4-yl]oxyphenyl]-2,4-dioxopyrimidine-5-carboxamide
   Show/Hide
C35H38FN9O5
 1
1
IC50 = 51 nM
   TI
   LI
   LO
   TS
CP0563666
N-[4-[2-[[2-(dimethylamino)acetyl]amino]pyridin-4-yl]oxyphenyl]-3-(4-fluorophenyl)-2,4-dioxo-1-propan-2-ylpyrimidine-5-carboxamide
   Show/Hide
C29H29FN6O5
 1
1
IC50 = 90 nM
   TI
   LI
   LO
   TS
CP0570986
3-(4-fluorophenyl)-1-methyl-N-[4-[6-[[4-(4-methylpiperazin-1-yl)piperidine-1-carbonyl]amino]pyrimidin-4-yl]oxyphenyl]-2,4-dioxopyrimidine-5-carboxamide
   Show/Hide
C33H36FN9O5
 1
1
IC50 = 173 nM
   TI
   LI
   LO
   TS
Biochemical Assays
Compound ID Compound Name Compound Formula
CP0033135
N-[2-[2-[4-(4-acetylpiperazin-1-yl)anilino]-5-(trifluoromethyl)pyrimidin-4-yl]-1,3-dihydroisoindol-4-yl]-N-methylmethanesulfonamide
   Show/Hide
C27H30F3N7O3S
 1
1 IC50 < 0.5 nM
CP0564219
3-(4-fluorophenyl)-N-[4-[2-[[2-(1-methylpiperidin-4-yl)acetyl]amino]pyridin-4-yl]oxyphenyl]-2,4-dioxo-1-propan-2-ylpyrimidine-5-carboxamide
   Show/Hide
C33H35FN6O5
 1
1 IC50 = 0.65 nM
CP0317631
N-[2,5-difluoro-4-[2-[[4-(4-methylpiperazin-1-yl)piperidine-1-carbonyl]amino]pyridin-4-yl]oxyphenyl]-3-(4-fluorophenyl)-2,4-dioxo-1-propan-2-ylpyrimidine-5-carboxamide
   Show/Hide
C36H39F3N8O5
 1
1 IC50 = 0.76 nM
CP0557698
N-[2-fluoro-4-[2-[[2-(1-methylpiperidin-4-yl)acetyl]amino]pyridin-4-yl]oxyphenyl]-3-(4-fluorophenyl)-2,4-dioxo-1-propan-2-ylpyrimidine-5-carboxamide
   Show/Hide
C33H34F2N6O5
 1
1 IC50 = 0.81 nM
CP0557697
N-[4-[6-(cyclopropanecarbonylamino)pyrimidin-4-yl]oxyphenyl]-3-(4-fluorophenyl)-2,4-dioxo-1-propan-2-ylpyrimidine-5-carboxamide
   Show/Hide
C28H25FN6O5
 1
1 IC50 = 0.85 nM
CP0031719
(R)-3-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)-5-(1-(piperidin-4-yl)-1H-pyrazol-4-yl)pyridin-2-amine
   Show/Hide
C21H22Cl2FN5O
 5
1 IC50 < 1 nM
2 IC50 = 294 nM
3 IC50 = 300 nM
4 IC50 > 100 nM
5 Kd = 7.8 nM
CP0562563
N-[2-[4-[(3S)-1-methylsulfonylpiperidin-3-yl]-1,3-thiazol-2-yl]-4-piperazin-1-ylphenyl]-1H-imidazole-2-carboxamide
   Show/Hide
C23H29N7O3S2
 1
1 IC50 = 1 nM
CP0563520
1-cyclopentyl-N-[3-fluoro-4-[2-[[2-(1-methylpiperidin-4-yl)acetyl]amino]pyridin-4-yl]oxyphenyl]-3-(4-fluorophenyl)-2,4-dioxopyrimidine-5-carboxamide
   Show/Hide
C35H36F2N6O5
 1
1 IC50 = 1.1 nM
CP0553502
N-[2,5-difluoro-4-[2-[[4-(4-methylpiperazin-1-yl)piperidine-1-carbonyl]amino]pyridin-4-yl]oxyphenyl]-2,5-dioxo-1-phenyl-7,8-dihydro-6H-quinoline-3-carboxamide
   Show/Hide
C38H39F2N7O5
 1
1 IC50 = 1.3 nM
CP0553501
1-cyclopentyl-3-(4-fluorophenyl)-N-[4-[6-[[4-(4-methylpiperazin-1-yl)piperidine-1-carbonyl]amino]pyrimidin-4-yl]oxyphenyl]-2,4-dioxopyrimidine-5-carboxamide
   Show/Hide
C37H42FN9O5
 1
1 IC50 = 1.5 nM
CP0562564
N-[4-[2-(dimethylamino)ethoxy]-2-[4-[(3S)-1-methylsulfonylpiperidin-3-yl]-1,3-thiazol-2-yl]phenyl]-1H-imidazole-2-carboxamide
   Show/Hide
C23H30N6O4S2
 1
1 IC50 = 1.8 nM
CP0543363
N-[4-[6-(azetidine-1-carbonylamino)pyrimidin-4-yl]oxyphenyl]-3-(4-fluorophenyl)-2,4-dioxo-1-propan-2-ylpyrimidine-5-carboxamide
   Show/Hide
C28H26FN7O5
 1
1 IC50 = 2 nM
CP0553500
3-(4-fluorophenyl)-N-[4-[6-[[4-(4-methylpiperazin-1-yl)piperidine-1-carbonyl]amino]pyrimidin-4-yl]oxyphenyl]-2,4-dioxo-1-propan-2-ylpyrimidine-5-carboxamide
   Show/Hide
C35H40FN9O5
 1
1 IC50 = 2 nM
CP0554517
3-(4-fluorophenyl)-2,4-dioxo-1-propan-2-yl-N-[4-[6-(pyrrolidine-1-carbonylamino)pyrimidin-4-yl]oxyphenyl]pyrimidine-5-carboxamide
   Show/Hide
C29H28FN7O5
 1
1 IC50 = 2.1 nM
CP0432863
N-[2-[4-[(2S)-4-methylsulfonylmorpholin-2-yl]-1,3-thiazol-2-yl]-4-morpholin-4-ylphenyl]-1H-imidazole-2-carboxamide
   Show/Hide
C22H26N6O5S2
 1
1 IC50 = 2.2 nM
CP0554516
1-cyclopropyl-N-[3-fluoro-4-[2-[[2-(1-methylpiperidin-4-yl)acetyl]amino]pyridin-4-yl]oxyphenyl]-3-(4-fluorophenyl)-2,4-dioxopyrimidine-5-carboxamide
   Show/Hide
C33H32F2N6O5
 1
1 IC50 = 2.5 nM
CP0004106
(2S,3R,4R,6R)-3-methoxy-2-methyl-4-(methylamino)-29-oxa-1,7,17-triazaoctacyclo[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]nonacosa-8(13),9,11,14(28),15(19),20(27),21(26),22,24-nonaen-16-one
   Show/Hide
C28H26N4O3
 5
1 IC50 = 3 nM
2 IC50 = 7.65 nM
3 IC50 = 11 nM
4 IC50 = 40 nM
5 Kd = 6.8 nM
CP0051488
N-[2-[4-[(3S)-1-methylsulfonylpiperidin-3-yl]-1,3-thiazol-2-yl]-4-morpholin-4-ylphenyl]-1H-imidazole-2-carboxamide
   Show/Hide
C23H28N6O4S2
 1
1 IC50 = 3.4 nM
CP0046394
BMS-907351
   Show/Hide
C28H24FN3O5
 3
1 IC50 = 3.4 nM
2 IC50 = 7 nM
3 IC50 = 9.5 nM
CP0563667
3-(4-fluorophenyl)-N-[4-[6-[(3-hydroxyazetidine-1-carbonyl)amino]pyrimidin-4-yl]oxyphenyl]-2,4-dioxo-1-propan-2-ylpyrimidine-5-carboxamide
   Show/Hide
C28H26FN7O6
 1
1 IC50 = 3.5 nM
CP0579678
1-(3,4-diazatricyclo[9.4.0.02,7]pentadeca-1(15),2,4,6,11,13-hexaen-5-yl)-3-N-[(7R)-7-pyrrolidin-1-yl-6,7,8,9-tetrahydro-5H-benzo[7]annulen-3-yl]-1,2,4-triazole-3,5-diamine
   Show/Hide
C30H34N8
 2
1 IC50 = 4.8 nM
2 IC50 = 14 nM
CP0178583
1-(3,4-diazatricyclo[9.4.0.02,7]pentadeca-1(15),2,4,6,11,13-hexaen-5-yl)-3-N-[(7S)-7-pyrrolidin-1-yl-6,7,8,9-tetrahydro-5H-benzo[7]annulen-3-yl]-1,2,4-triazole-3,5-diamine
   Show/Hide
C30H34N8
 4
1 IC50 = 5 nM
2 IC50 = 5.3 nM
3 IC50 = 14 nM
4 IC50 = 650 nM
CP0317629
3-(4-fluorophenyl)-2,4-dioxo-1-propan-2-yl-N-[4-[6-[(3-pyrrolidin-1-ylazetidine-1-carbonyl)amino]pyrimidin-4-yl]oxyphenyl]pyrimidine-5-carboxamide
   Show/Hide
C32H33FN8O5
 1
1 IC50 = 5.6 nM
CP0317628
3-(4-fluorophenyl)-N-[4-[6-[[3-(methylamino)azetidine-1-carbonyl]amino]pyrimidin-4-yl]oxyphenyl]-2,4-dioxo-1-propan-2-ylpyrimidine-5-carboxamide
   Show/Hide
C29H29FN8O5
 1
1 IC50 = 6.4 nM
CP0178584
3-[[(3Z)-3-[[4-(morpholin-4-ylmethyl)-1H-pyrrol-2-yl]methylidene]-2-oxo-1H-indol-5-yl]methyl]-1,3-thiazolidine-2,4-dione
   Show/Hide
C22H22N4O4S
 1
1 IC50 = 7 nM
CP0100843
1-N'-[4-(6,7-dimethoxyquinolin-4-yl)oxy-3-fluorophenyl]-1-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
   Show/Hide
C28H23F2N3O5
 1
1 IC50 = 7 nM
CP0566934
1-cyclopropyl-3-(4-fluorophenyl)-N-[4-[6-[[4-(4-methylpiperazin-1-yl)piperidine-1-carbonyl]amino]pyrimidin-4-yl]oxyphenyl]-2,4-dioxopyrimidine-5-carboxamide
   Show/Hide
C35H38FN9O5
 1
1 IC50 = 7.1 nM
CP0043052
FORETINIB
   Show/Hide
C34H34F2N4O6
 2
1 IC50 = 11 nM
2 Kd = 0.093 nM
CP0563666
N-[4-[2-[[2-(dimethylamino)acetyl]amino]pyridin-4-yl]oxyphenyl]-3-(4-fluorophenyl)-2,4-dioxo-1-propan-2-ylpyrimidine-5-carboxamide
   Show/Hide
C29H29FN6O5
 1
1 IC50 = 11 nM
CP0024455
5-cyano-N-[2-(cyclohexen-1-yl)-4-[1-[2-(dimethylamino)acetyl]piperidin-4-yl]phenyl]-1H-imidazole-2-carboxamide
   Show/Hide
C26H32N6O2
 1
1 IC50 = 12 nM
CP0051296
CHEMBL3326006
   Show/Hide
C28H40N6O
 1
1 IC50 = 14 nM
CP0115042
2-[[5-chloro-2-[4-[(4-methylpiperazin-1-yl)methyl]anilino]pyrimidin-4-yl]amino]-N,N-dimethylbenzenesulfonamide
   Show/Hide
C24H30ClN7O2S
 2
1 IC50 = 15 nM
2 IC50 = 27 nM
CP0402661
N-[2-[4-[(2S)-4-methylsulfonylmorpholin-2-yl]-1,3-thiazol-2-yl]phenyl]-1H-imidazole-2-carboxamide
   Show/Hide
C18H19N5O4S2
 1
1 IC50 = 25 nM
CP0566910
N-[4-(6,7-dimethoxyquinolin-4-yl)oxy-3-fluorophenyl]-4-ethoxy-1-(4-fluoro-2-methylphenyl)pyrazole-3-carboxamide
   Show/Hide
C30H26F2N4O5
 1
1 IC50 = 29 nM
CP0570986
3-(4-fluorophenyl)-1-methyl-N-[4-[6-[[4-(4-methylpiperazin-1-yl)piperidine-1-carbonyl]amino]pyrimidin-4-yl]oxyphenyl]-2,4-dioxopyrimidine-5-carboxamide
   Show/Hide
C33H36FN9O5
 1
1 IC50 = 32 nM
CP0155152
N-[2-[4-[(3S)-1-methylsulfonylpiperidin-3-yl]-1,3-thiazol-2-yl]phenyl]-1H-imidazole-2-carboxamide
   Show/Hide
C19H21N5O3S2
 1
1 IC50 = 33 nM
CP0545741
4-[4-[5-[imidazo[1,2-a]pyridin-6-ylmethyl(methyl)amino]-1,3,4-oxadiazol-2-yl]-3-methylphenyl]-2,5-dimethylpyrazole-3-carbonitrile
   Show/Hide
C24H22N8O
 1
1 IC50 = 39.81 nM
CP0245111
N-(imidazo[1,2-a]pyridin-6-ylmethyl)-N-methyl-5-[2-methyl-4-(1,3,5-trimethylpyrazol-4-yl)phenyl]-1,3,4-oxadiazol-2-amine
   Show/Hide
C24H25N7O
 1
1 IC50 = 79.43 nM
CP0494149
5-[2-chloro-4-(1,3,5-trimethylpyrazol-4-yl)phenyl]-N-(imidazo[1,2-a]pyridin-6-ylmethyl)-N-methyl-1,3,4-oxadiazol-2-amine
   Show/Hide
C23H22ClN7O
 1
1 IC50 = 79.43 nM
CP0115610
CHEMBL4283353
   Show/Hide
C30H44N6O
 2
1 IC50 = 80 nM
2 Ki = 40.22 nM
CP0354548
5-[4-(1,5-dimethylpyrazol-4-yl)-2-methylphenyl]-N-(imidazo[1,2-a]pyridin-6-ylmethyl)-N-methyl-1,3,4-oxadiazol-2-amine
   Show/Hide
C23H23N7O
 1
1 IC50 = 100 nM
CP0329747
(2,6-dimethylpyridin-4- yl)(4-(7-((1R,4S)-4- hydroxycyclohexyl)-2- (((S)-pentan-2-yl)amino)- 7H-pyrrolo[2,3- d]pyrimidin-5-yl)piperidin- 1-yl)methanone
   Show/Hide
C30H42N6O2
 2
1 IC50 = 140 nM
2 Ki = 97.5 nM
CP0915359
(R)-6-chloro-3-(1-(4-methoxyphenyl)-1H-pyrazol-4-yl)-N-(pyrrolidin-3-yl)-1H-indazol-5-amine
   Show/Hide
C21H21ClN6O
 1
1 IC50 = 300 nM
CP0960720
(R)-4-(4-(6-chloro-5-(pyrrolidin-3-ylamino)-1H-indazol-3-yl)-1H-pyrazol-1-yl)benzonitrile
   Show/Hide
C21H18ClN7
 1
1 IC50 = 700 nM
CP0257794
N-(imidazo[1,2-a]pyridin-6-ylmethyl)-5-[2-methoxy-4-(1,3,5-trimethylpyrazol-4-yl)phenyl]-N-methyl-1,3,4-oxadiazol-2-amine
   Show/Hide
C24H25N7O2
 1
1 IC50 = 794.33 nM
CP0554525
N-(imidazo[1,2-a]pyridin-6-ylmethyl)-N-methyl-5-[3-methyl-5-(1,3,5-trimethylpyrazol-4-yl)pyridin-2-yl]-1,3,4-oxadiazol-2-amine
   Show/Hide
C23H24N8O
 1
1 IC50 = 1000 nM
CP0955678
(R)-6-chloro-3-(1-(4-methoxyphenyl)-1H-pyrazol-4-yl)-N-(5-azaspiro[2.4]heptan-7-yl)-1H-indazol-5-amine
   Show/Hide
C23H23ClN6O
 1
1 IC50 = 1000 nM
CP0343136
5-[2-fluoro-4-(1,3,5-trimethylpyrazol-4-yl)phenyl]-N-(imidazo[1,2-a]pyridin-6-ylmethyl)-N-methyl-1,3,4-oxadiazol-2-amine
   Show/Hide
C23H22FN7O
 1
1 IC50 = 1258.93 nM
CP0553528
N-(imidazo[1,2-a]pyridin-6-ylmethyl)-N-methyl-5-[4-(1,3,5-trimethylpyrazol-4-yl)phenyl]-1,3,4-oxadiazol-2-amine
   Show/Hide
C23H23N7O
 1
1 IC50 = 1258.93 nM
CP0775775
(R)-6-chloro-3-(1-phenyl-1H-pyrazol-4-yl)-N-(pyrrolidin-3-yl)-1H-indazol-5-amine
   Show/Hide
C20H19ClN6
 1
1 IC50 = 1700 nM
CP0775776
(R)-6-chloro-3-(1-(4-fluorophenyl)-1H-pyrazol-4-yl)-N-(pyrrolidin-3-yl)-1H-indazol-5-amine
   Show/Hide
C20H18ClFN6
 1
1 IC50 = 2300 nM
CP0968870
(R)-3-(4-(6-chloro-5-(pyrrolidin-3-ylamino)-1H-indazol-3-yl)-1H-pyrazol-1-yl)benzonitrile
   Show/Hide
C21H18ClN7
 1
1 IC50 = 2300 nM
CP0368045
N-(imidazo[1,2-a]pyridin-6-ylmethyl)-N-methyl-5-[2-methyl-6-(1,3,5-trimethylpyrazol-4-yl)pyridin-3-yl]-1,3,4-oxadiazol-2-amine
   Show/Hide
C23H24N8O
 1
1 IC50 = 3162.28 nM
CP0950734
(R)-2-(4-(6-chloro-5-(pyrrolidin-3-ylamino)-1H-indazol-3-yl)-1H-pyrazol-1-yl)benzonitrile
   Show/Hide
C21H18ClN7
 1
1 IC50 = 3200 nM
CP0480275
N-(imidazo[1,2-a]pyridin-6-ylmethyl)-N-methyl-5-[2-methyl-4-(2,3,5-trimethylimidazol-4-yl)phenyl]-1,3,4-oxadiazol-2-amine
   Show/Hide
C24H25N7O
 1
1 IC50 = 3981.07 nM
CP0018808
4-(cyclopentylamino)-2-[(2,5-dichlorophenyl)methylamino]-N-[3-(2-oxo-1,3-oxazolidin-3-yl)propyl]pyrimidine-5-carboxamide
   Show/Hide
C23H28Cl2N6O3
 2
1 IC50 = 3990 nM
2 Kd = 1700 nM
CP0958999
(R)-6-chloro-3-(1-(2-fluoroethyl)-1H-pyrazol-4-yl)-N-(pyrrolidin-3-yl)-1H-indazol-5-amine
   Show/Hide
C16H18ClFN6
 1
1 IC50 = 5000 nM
CP0271463
5-[4-(3,5-dimethyl-1H-pyrazol-4-yl)-2-methylphenyl]-N-(imidazo[1,2-a]pyridin-6-ylmethyl)-N-methyl-1,3,4-oxadiazol-2-amine
   Show/Hide
C23H23N7O
 1
1 IC50 = 5011.87 nM
CP0487262
4-[4-[5-[imidazo[1,2-a]pyridin-6-ylmethyl(methyl)amino]-1,3,4-oxadiazol-2-yl]-3-methylphenyl]-1,5-dimethylpyrazole-3-carbonitrile
   Show/Hide
C24H22N8O
 1
1 IC50 = 6309.57 nM
CP0955676
(R)-6-chloro-3-(1-methyl-1H-pyrazol-4-yl)-N-(pyrrolidin-3-yl)-1H-indazol-5-amine
   Show/Hide
C15H17ClN6
 1
1 IC50 = 19000 nM
CP0955675
(R)-3-(1-methyl-1H-pyrazol-4-yl)-N-(pyrrolidin-3-yl)-1H-indazol-5-amine
   Show/Hide
C15H18N6
 1
1 IC50 = 37000 nM
CP0775778
(R)-6-chloro-3-(1-(4-methoxyphenyl)-1H-pyrazol-4-yl)-N-(1-(oxetan-3-yl)pyrrolidin-3-yl)-1H-indazol-5-amine
   Show/Hide
C24H25ClN6O2
 1
1 IC50 = 41500 nM
CP0245112
5-[4-[1-(difluoromethyl)-3,5-dimethylpyrazol-4-yl]-2-methylphenyl]-N-(imidazo[1,2-a]pyridin-6-ylmethyl)-N-methyl-1,3,4-oxadiazol-2-amine
   Show/Hide
C24H23F2N7O
 1
1 IC50 = 63095.73 nM
CP0915358
(R)-6-chloro-3-(1-methyl-1H-pyrazol-4-yl)-N-(1-methylpyrrolidin-3-yl)-1H-indazol-5-amine
   Show/Hide
C16H19ClN6
 1
1 IC50 = 74000 nM
CP0958808
(S)-3-(1-methyl-1H-pyrazol-4-yl)-N-(pyrrolidin-3-yl)-1H-indazol-5-amine
   Show/Hide
C15H18N6
 1
1 IC50 = 239000 nM
CP0540377
2-[5-[imidazo[1,2-a]pyridin-6-ylmethyl(methyl)amino]-1,3,4-oxadiazol-2-yl]-5-(1,3,5-trimethylpyrazol-4-yl)benzonitrile
   Show/Hide
C24H22N8O
 1
1 IC50 > 100000 nM
Clinical Information about the Protein
Target 1 ( Tyrosine-protein kinase UFO (AXL) )
Target Type Successful Target
Disease 4 Target-related Diseases  4
1 Acute myeloid leukaemia [ICD-11: 2A60]
2 Non-small-cell lung cancer [ICD-11: 2C25.Y]
3 Solid tumour/cancer [ICD-11: 2A00-2F9Z]
4 Chronic lymphocytic leukaemia [ICD-11: 2A82.0]
Approved Drug(s) 1 Approved Drug  1
1 Gilteritinib Approved
Acute myeloid leukaemia
Clinical Trial Drug(s) 4 Clinical Trial Drugs  4
1 Bemcentinib Phase 2
Non-small-cell lung cancer
2 MGCD265 Phase 2
Non-small-cell lung cancer
3 RXDX-106 Phase 1
Solid tumour/cancer
4 TP-0903 Phase 1/2
Chronic lymphocytic leukaemia
Similar Protein(s) and Bioactivity Statistics
50% Identity
Protein ID Protein Name Protein Organism
PT07477 Tyrosine-protein kinase receptor UFO Mus musculus, Mouse